Related references
Note: Only part of the references are listed.Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells
Zhongguang Luo et al.
AUTOPHAGY (2012)
TRAF6 inhibits proangiogenic signals in endothelial cells and regulates the expression of vascular endothelial growth factor
Sarah Bruneau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth
Zhongguang Luo et al.
CANCER RESEARCH (2012)
DEPTOR Cell-Autonomously Promotes Adipogenesis, and Its Expression Is Associated with Obesity
Mathieu Laplante et al.
CELL METABOLISM (2012)
Targeting the intragraft microenvironment and the development of chronic allograft rejection
Olivier Dormond et al.
HUMAN IMMUNOLOGY (2012)
Targeting the mTOR-DEPTOR Pathway by CRL E3 Ubiquitin Ligases: Therapeutic Application
Yongchao Zhao et al.
NEOPLASIA (2012)
The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitors
Anne Dormond-Meuwly et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The Identification of Raptor as a Substrate for p44/42 MAPK
Paul Langlais et al.
ENDOCRINOLOGY (2011)
The resolution of inflammation: the devil in the flask and in the details
Charles N. Serhan
FASEB JOURNAL (2011)
DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy
Yongchao Zhao et al.
MOLECULAR CELL (2011)
mTOR Generates an Auto-Amplification Loop by Triggering the βTrCP- and CK1α-Dependent Degradation of DEPTOR
Shanshan Duan et al.
MOLECULAR CELL (2011)
mTOR Drives Its Own Activation via SCFβTrCP-Dependent Degradation of the mTOR Inhibitor DEPTOR
Daming Gao et al.
MOLECULAR CELL (2011)
Deptor Knockdown Enhances mTOR Activity and Protein Synthesis in Myocytes and Ameliorates Disuse Muscle Atrophy
Abid A. Kazi et al.
MOLECULAR MEDICINE (2011)
Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40
Aninda Basu et al.
PLOS ONE (2011)
Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo
Monika Edelbauer et al.
BLOOD (2010)
Resveratrol Inhibits mTOR Signaling by Promoting the Interaction between mTOR and DEPTOR
Meilian Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
Timothy R. Peterson et al.
CELL (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1
Christian C. Dibble et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Dynamic Balancing: DEPTOR Tips the Scales
Christopher G. Proud
JOURNAL OF MOLECULAR CELL BIOLOGY (2009)
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
Valeria Facchinetti et al.
EMBO JOURNAL (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Evolving functions of endothelial cells in inflammation
Jordan S. Pober et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells
Olivier Dormond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Resolution of inflammation: state of the art, definitions and terms
Charles N. Serhan et al.
FASEB JOURNAL (2007)
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
Thuy L. Phung et al.
CANCER CELL (2006)
Angiogenesis and endothelial cell repair in renal disease and allograft rejection
Marlies E. J. Reinders et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-γ-Inducible protein of 10 kDa in vitro and in vivo
Gwenola Boulday et al.
JOURNAL OF IMMUNOLOGY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Regulation of STAT1 nuclear export by Jak1
K Mowen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
